Search
for
Sort by
Research 151–180 of 345
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- A rash diagnosis
- Dermatologic Adverse Events from Cancer Treatments
- Cutaneous Manifestations of Lupus Erythematosus
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Skin manifestations associated with systemic diseases – Part I
- Exploring Pediatric Dermatology in Skin of Color: Focus on Dermoscopy
- Raising awareness of Demodex mites: a neglected cause of skin disease
- Atlas of Geriatric Dermatology
- Drug eruptions in dermatology
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Cutaneous drug reactions
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- General Dermatology
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Cutaneous manifestations of COVID-19: a case report and review of the literature
- Adverse cutaneous effects of psychotropic medications
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Dermatological Drugs, Topical Agents, and Cosmetics
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Fixed-Drug Eruption due to Dextromethorphan
- Clin-Alert
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Secondary syphilis presenting with alopecia and leukoderma in a stable HIV-positive patient in a resource-limited setting: a case report
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- Safety Evaluation of Topical Valproate Application
- Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review